Is response to allergen immunotherapy a good phenotypic marker for differentiating between allergic rhinitis and mixed rhinitis?

Allergy and Asthma Proceedings

Volumn 32, Issue 1, 2011, Pages 49-54

  Smith, Andrew M ^a   Rezvani, Maziar ^a   Bernstein, Jonathan A ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; ANTIHISTAMINIC AGENT; CORTICOSTEROID; DECONGESTIVE AGENT;

ADULT; ALLERGIC RHINITIS; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HUMAN; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MIXED RHINITIS; PHENOTYPIC VARIATION; RHINITIS; SINUSITIS; TREATMENT OUTCOME;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; CRESOLS; DESENSITIZATION, IMMUNOLOGIC; DIAGNOSIS, DIFFERENTIAL; DRUG COMBINATIONS; FEMALE; FORMALDEHYDE; HUMANS; MALE; MIDDLE AGED; RESORCINOLS; RHINITIS, ALLERGIC, PERENNIAL; RHINITIS, ALLERGIC, SEASONAL; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79251641979     PISSN: 10885412     EISSN: 15396304     Source Type: Journal    
DOI: 10.2500/aap.2011.32.3400     Document Type: Article

References (13)

1. Bernstein IL, Li JT, Bernstein DI, et al. American Academy of Allergy, Asthma and Immunology; American College of Allergy, Asthma and Immunology. Allergy diagnostic testing: an updated practice parameter. Ann Allergy Asthma Immunol 100(suppl 3):S1-S148, 2008.
2. Wallace DV, Dykewicz MS, Bernstein DI, et al. Task Force on Practice; American Academy of Allergy; Asthma and Immunology; American College of Allergy; Asthma and Immunology; Joint Council of Allergy, Asthma and Immunology. The diagnosis and management of rhinitis: an updated practice parameter. J Allergy Clin Immunol 122:S1-S84, 2008.
3. Settipane RA, and Lieberman P. Update on nonallergic rhinitis. Ann Allergy Asthma Immunol 86:494-507, 2001.
4. Bernstein JA, Brandt D, Ratner P, and Wheeler W. Assessment of a rhinitis questionnaire in a seasonal allergic rhinitis population. Ann Allergy Asthma Immunol 100:512-513, 2008.
5. Brandt D, and Bernstein JA. Questionnaire evaluation and risk factor identification for non-allergic vasomotor rhinitis. Ann Allergy Asthma Immunol. 96:526-532, 2006.
6. Nassef M, Shapiro G, and Casale TB. Identifying and managing rhinitis and its subtypes: Allergic and nonallergic components: A consensus report and materials for the Respiratory and Allergic Disease Foundation. Curr Med Res Opin 22:2541-2548, 2006. (Pubitemid 46048369)
7. Bernstein JA, and Rezvani M. Mixed rhinitis: A new subclass of chronic rhinitis? In Current Reviews of Rhinitis, 2nd ed. Kaliner M (Ed). Philadelphia, PA: Current Medicine, Inc., 69-78, 2006.
8. Bousquet J, Lockey RF, Malling H.-J., et al. WHO Position Paper: Allergen Immunotherapy: Therapeutic vaccines for allergic diseases. Eur J Allergy Clin Immunol 53:1-42, 1998. (Pubitemid 28346358)
9. Cox L, Li JT, Nelson H, and Lockey R (eds.). Allergen immunotherapy: A practice parameter second update. J Allergy Clin Immunol 120:S25-S85, 2007.
10. Bernstein JA. Characteristics of non-allergic rhinitis. World Allergy J l 2:102-105, 2009.
11. Hankin CS, Cox L, Lang D, et al. Allergen immunotherapy and health care cost benefits for children with allergic rhinitis: A large-scale, retrospective, matched cohort study. Ann Allergy Asthma Immunol 104:79-85, 2010.
12. Meltzer EO, Nathan R, Derebery J, et al. Sleep, quality of life, and productivity impact of nasal symptoms in the United States: Findings from the Burden of Rhinitis in America survey. Allergy Asthma Proc 30:244-254, 2009.
13. Nathan RA, Meltzer EO, Derebery J, et al. The prevalence of nasal symptoms attributed to allergies in the United States: Findings from the burden of rhinitis in an America survey. Allergy Asthma Proc 29:600-608, 2008.